CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 106 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,208 | -99.9% | 360 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $3,431,501 | -38.4% | 255,320 | -24.0% | 0.32% | -34.0% |
| Q1 2023 | $5,569,222 | -16.8% | 335,900 | -6.6% | 0.48% | -15.7% |
| Q4 2022 | $6,692,280 | +8.3% | 359,800 | -25.3% | 0.57% | +1.3% |
| Q3 2022 | $6,180,000 | +34.5% | 481,700 | -26.5% | 0.56% | +51.9% |
| Q2 2022 | $4,595,000 | -14.7% | 655,600 | +0.9% | 0.37% | +5.7% |
| Q1 2022 | $5,388,000 | +8063.6% | 649,900 | +3722.9% | 0.35% | +3063.6% |
| Q4 2017 | $66,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |